Targeting the eukaryotic translation initiation factor 4E for cancer therapy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Research

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-07-5635PMID 18245460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.

  2008cited by this paper
• Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity.

  2008cited by this paper
• Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.

  2007influential reference
• Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.

  2007cited by this paper
• 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.

  2007cited by this paper
• Reduction of translation initiation factor 4E decreases the malignancy of ras ‐transformed cloned rat embryo fibroblasts

  2006cited by this paper
• RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.

  2006cited by this paper
• A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer.

  2005cited by this paper
• Translation Initiation Factor 4E Blocks Endoplasmic Reticulum-mediated Apoptosis*

  2004cited by this paper
• eIF-4E expression and its role in malignancies and metastases

  2004influential reference
• Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

  2004cited by this paper
• Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap

  2004cited by this paper
• Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells.

  2004cited by this paper
• The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

  2004cited by this paper
• Addiction to Oncogenes--the Achilles Heal of Cancer

  2002cited by this paper
• Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis.

  2000cited by this paper
• Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E.

  2000cited by this paper
• Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.

  1996cited by this paper
• The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth.

  1996cited by this paper
• Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts.

  1995cited by this paper
• Decreasing the level of translation initiation factor 4E with antisense rna causes reversal of ras‐mediated transformation and tumorigenesis of cloned rat embryo fibroblasts

  1993cited by this paper
• Ras mediates translation initiation factor 4E-induced malignant transformation.

  1992cited by this paper
• Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap

  1990cited by this paper

• Chemical Probes for Studying the Eukaryotic Translation Initiation Factor 4E (eIF4E)-Regulated Translatome in Cancer.

  2025cites this paper
• Peptide design to control protein–protein interactions

  2025cites this paper
• PRSS23-eIF4E-c-Myc axis promotes gastric tumorigenesis and progression

  2025cites this paper
• The Proteins Diversity of the eIF4E Family in the eIF4F Complex

  2025cites this paper
• MNK: A Novel Promising Target for Cancer Immunotherapy.

  2024cites this paper
• Systems Biology Methods via Genome-Wide RNA Sequences to Investigate Pathogenic Mechanisms for Identifying Biomarkers and Constructing a DNN-Based Drug–Target Interaction Model to Predict Potential Molecular Drugs for Treating Atopic Dermatitis

  2024cites this paper
• MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis

  2023cites this paper
• Visualization of breast cancer-related protein synthesis from the perspective of bibliometric analysis

  2023cites this paper
• Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer

  2023cites this paper
• Biological functions and research progress of eIF4E

  2023influential citation
• VNLG-152R and its deuterated analogs potently inhibit/repress triple/quadruple negative breast cancer of diverse racial origins in vitro and in vivo by upregulating E3 Ligase Synoviolin 1 (SYVN1) and inducing proteasomal degradation of MNK1/2

  2023cites this paper
• The role of atypical MAP kinase 4 in the host interaction with Cryptosporidium parvum

  2023cites this paper
• Inhibition of Eukaryotic Initiating Factor eIF4E Overcomes Abemaciclib Resistance in Gastric Cancer

  2023cites this paper
• The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches.

  2023cites this paper
• Inverse Molecular Docking Elucidating the Anticarcinogenic Potential of the Hop Natural Product Xanthohumol and Its Metabolites

  2022cites this paper
• Signaling pathways and therapeutic interventions in gastric cancer

  2022cites this paper
• Visible light–initiated radical 1,3-difunctionalization of β,γ-unsaturated ketones

  2022cites this paper
• Targeting DEAD‐box RNA helicases: The emergence of molecular staples

  2022cites this paper
• Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathways.

  2021cites this paper
• Activation of ERK and p38 Reduces AZD8055-Mediated Inhibition of Protein Synthesis in Hepatocellular Carcinoma HepG2 Cell Line

  2021cites this paper
• Biguanides drugs: Past success stories and promising future for drug discovery.

  2021cites this paper
• A highly annotated database of genes associated with platinum resistance in cancer

  2021cites this paper
• Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5.

  2021cites this paper
• Nucleotide-decorated AuNPs as probes for nucleotide-binding proteins

  2021cites this paper
• Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A

  2021cites this paper
• Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers.

  2021cites this paper
• Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.

  2020cites this paper
• Targeting the phosphatidylinositol 3-kinase signaling pathway in acute myeloid leukemia

  2020cites this paper
• Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway

  2020cites this paper
• Impact of Eukaryotic Translation Initiation Factors on Breast Cancer: Still Much to Investigate

  2020cites this paper
• Clinical significance of PI3K/Akt/mTOR signaling in gastric carcinoma.

  2020influential citation
• Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway

  2020cites this paper
• A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions.

  2020cites this paper
• Salubrinal in Combination With 4E1RCat Synergistically Impairs Melanoma Development by Disrupting the Protein Synthetic Machinery

  2020cites this paper
• Deep computational analysis of human cancer and non-cancer tissues details dysregulation of eIF4F components and their interactions in human cancers

  2020cites this paper
• Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity

  2020influential citation
• Clinical implications of intratumor heterogeneity: challenges and opportunities

  2020cites this paper
• Novel Regularization Method for Biomarker Selection and Cancer Classification

  2020cites this paper
• Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway

  2020cites this paper
• Coordination of gene expression programs

  2020cites this paper
• GHR, PEX5 AND AXIN2 ARE NEW TARGETS FOR MIR-195 IN- VOLVING IN LONGEVITY, INCREASING BIOLOGICAL ACTIVI- TIES AND EMT OF CANCER CELLS FOR HEPATOCELLULAR CARCINOMA CELLS

  2020cites this paper
• Protein-protein interaction modulators: advances, successes and remaining challenges

  2019cites this paper
• Chrysin and its relation with gastric cancer

  2019cites this paper
• The eukaryotic initiation factor 4E (eIF4E) as a predictive biomarker in the negative margins of resected head and neck and oral cancers: Is there a role for tailoring adjuvant radiotherapy

  2019cites this paper
• eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer

  2019cites this paper
• Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 Inhibitor

  2019cites this paper
• Targeting the translational machinery in aggressive cancers

  2019influential citation
• Translational Regulation by Upstream Open Reading Frames and Human Diseases.

  2019cites this paper
• The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?

  2019cites this paper
• A Network-based Analysis of Hepatocellular Carcinoma

  2019cites this paper
• Reciprocal interplay of miR-497 and MALAT1 promotes tumourigenesis of adrenocortical cancer.

  2019cites this paper
• O‐GlcNAc transferase activates stem‐like cell potential in hepatocarcinoma through O‐GlcNAcylation of eukaryotic initiation factor 4E

  2019cites this paper
• eIF4E-related miR-320a and miR-340-5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF-β1-induced epithelial-mesenchymal transition

  2019cites this paper
• Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in lung adenocarcinoma.

  2019cites this paper
• Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling

  2019cites this paper
• Fluorescent Turn-On Probes for the Development of Binding and Hydrolytic Activity Assays for mRNA Cap-Recognizing Proteins.

  2019cites this paper
• NanoTRAIL‐Oncology: A Strategic Approach in Cancer Research and Therapy

  2018cites this paper
• Beyond molecular tumor heterogeneity: protein synthesis takes control

  2018cites this paper
• TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies.

  2018cites this paper
• Signaling Pathways Involved in the Regulation of mRNA Translation

  2018cites this paper
• Integrin β1 mediates 5-fluorouracil chemoresistance under translational control of eIF4E in colorectal cancer.

  2018cites this paper
• Abstract. The eukaryotic initiation factor (eIF)4E-binding proteins (4E-BPs) regulate cap-dependent protein translation and control the assembly of the eIF4F complex. In the present study, a phosphorylation‐deficient truncated 4E‐BP2 (eIF4FD) was constructed into the eukaryotic expression vector pSe

  2018cites this paper
• Contrôle traductionnel des fonctions des macrophages par les répresseurs 4E-BP1 et 4E-BP2

  2018cites this paper
• Gene Expression Differences in Pediatric Lymphatic Malformations: Size Really Matters

  2018cites this paper
• The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer

  2018cites this paper
• The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo

  2018cites this paper
• Personalized Bladder Cancer Management

  2018cites this paper
• The retinamide VNLG‐152 inhibits f‐AR/AR‐V7 and MNK–eIF4E signaling pathways to suppress EMT and castration‐resistant prostate cancer xenograft growth

  2018cites this paper
• RNA Nuclear Export: From Neurological Disorders to Cancer.

  2017cites this paper
• Downregulation of eukaryotic initiation factor 4A1 improves radiosensitivity by delaying DNA double strand break repair in cervical cancer.

  2017cites this paper
• Phosphoproteomics of colon cancer metastasis: comparative mass spectrometric analysis of the isogenic primary and metastatic cell lines SW480 and SW620

  2017cites this paper
• Targeting of protein translation as a new treatment paradigm for prostate cancer

  2017cites this paper
• Cancer as an ecomolecular disease and a neoplastic consortium.

  2017cites this paper
• Recombinant human erythropoietin stimulates melanoma tumor growth through activation of initiation factor eIF4E

  2017cites this paper
• Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas

  2017cites this paper
• Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5

  2017cites this paper
• Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers.

  2017cites this paper
• Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors.

  2017cites this paper
• Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action

  2017cites this paper
• Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E

  2017cites this paper
• The histone demethylase KDM5A is required for the repression of astrocytogenesis and regulated by the translational machinery in neural progenitor cells

  2017cites this paper
• Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma

  2017cites this paper
• Radiation-induced translational control of gene expression

  2017cites this paper
• Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.

  2017cites this paper
• University of Dundee mTORC 1 and CK 2 coordinate ternary and eIF 4 F complex assembly

  2017cites this paper
• Computer simulation of a large-scale signalling network regulating translation Initiation in the mammalian cell.

  2017cites this paper
• Neural Stem Cell Activation and the Role of Protein Synthesis

  2017cites this paper
• Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.

  2017cites this paper
• A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance

  2017cites this paper
• mTOR-sensitive translation: Cleared fog reveals more trees

  2017cites this paper
• MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells*

  2016cites this paper
• mTORC1 and CK2 coordinate ternary and eIF4F complex assembly

  2016cites this paper
• Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin.

  2016cites this paper
• Quantitative expression of the eukaryotic translation initiation factor 4E (eIF4E) in egyptian acute leukemia patients and its clinical significance

  2016cites this paper
• Enhancement of oncolytic herpes simplex type 1 virotherapy

  2016cites this paper
• eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma

  2016cites this paper
• Metabolic Shunt Pathways, Carcinoma, and mTOR

  2016cites this paper
• Usnic acid is a novel Pim-1 inhibitor with the abilities of inhibiting growth and inducing apoptosis in human myeloid leukemia cells

  2016cites this paper
• The Evolving Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in Renal Cell Carcinoma

  2016cites this paper
• Investigating Male Breast Cancer Using Transcriptomics and Immunohistochemistry

  2016cites this paper